Gsk (GLAXF) Gross Profit (2009 - 2026)

Gsk's Gross Profit history runs 18 years deep, the most recent figure standing at $7.8 billion for Q1 2026.

• In Q1 2026, Gross Profit rose 10.4% year-over-year to $7.8 billion; the TTM figure through Mar 2026 stood at $31.9 billion (down 11.07% YoY), while the FY2025 annual figure was $31.2 billion, up 9.25% from the prior year.
• Gross Profit was $7.8 billion for Q1 2026 at Gsk, down from $7.9 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $14.3 billion in Q4 2024 to a low of $6.0 billion in Q2 2022.
• Historically, Gross Profit has averaged $8.0 billion across 5 years, with a median of $7.3 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Gross Profit jumped 87.08% in 2022, then sank 44.62% in 2025.
• A 5-year view of Gross Profit shows it stood at $10.8 billion in 2022, then rose by 17.61% to $12.7 billion in 2023, then climbed by 12.5% to $14.3 billion in 2024, then slumped by 44.62% to $7.9 billion in 2025, then declined by 2.17% to $7.8 billion in 2026.
• The last three Gross Profit figures came in at $7.8 billion (Q1 2026), $7.9 billion (Q4 2025), and $8.5 billion (Q3 2025), per Business Quant data.